Nicotinic acetylcholine receptor ligands 101

Details for Australian Patent Application No. 2007250560 (hide)

Owner AstraZeneca AB

Inventors Phillips, Eifion; Holmquist, Christopher; Simpson, Thomas; Chang, Hui-Fang; Urbanek, Rebecca; Xiong, Hui; Piser, Timothy; Woods, James

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2007250560

PCT Pub. Number WO2007/133155

Priority 60/824,975 08.09.06 US; 60/747,476 17.05.06 US

Filing date 16 May 2007

Wipo publication date 22 November 2007

Acceptance publication date 23 June 2011

International Classifications

C07D 491/22 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/34 (2006.01) Drugs for disorders of the nervous system

Event Publications

11 December 2008 PCT application entered the National Phase

  PCT publication WO2007/133155 Priority application(s): WO2007/133155

23 June 2011 Application Accepted

  Published as AU-B-2007250560

20 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007250569-Antigen capture anti-dengue IgA ELISA (ACA-ELISA) for the detection of a flavivirus specific antibody

2007250558-Improved antimicrobial peptides